LCDX (Caliber Imaging & Diagnostics) Research & Development: $1.47 Mil (TTM As of Mar. 2014)


What is Caliber Imaging & Diagnostics Research & Development?

Caliber Imaging & Diagnostics LCDX Research & Development is $1.47 Mil as of Mar. 2014.

Research & Development is the aggregate amount of research and development expenses during the year. Caliber Imaging & Diagnostics's Research & Development for the three months ended in Mar. 2014 was $0.39 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2014 was $1.47 Mil.

Caliber Imaging & Diagnostics  (OTCPK:LCDX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Caliber Imaging & Diagnostics Research & Development Related Terms

Caliber Imaging & Diagnostics Research & Development Historical Data

* Premium members only.

The historical data trend for Caliber Imaging & Diagnostics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caliber Imaging & Diagnostics Research & Development Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
Research & Development
0.76 0.69 1.46 3.77 1.53

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.34 0.36 0.38 0.39

Caliber Imaging & Diagnostics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.47 Mil mean?
Caliber Imaging & Diagnostics (LCDX) has a Research & Development of $1.47 Mil as of Mar. 2014. Research and development expense is the total cost for research and development activities. View historical data on Caliber Imaging & Diagnostics and its competitors.
Is Caliber Imaging & Diagnostics' Research & Development too high?
Caliber Imaging & Diagnostics' current Research & Development is $1.47 Mil.
How does Caliber Imaging & Diagnostics' Research & Development compare to VICA and CRVW?
Caliber Imaging & Diagnostics' Research & Development of $1.47 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Caliber Imaging & Diagnostics and its competitors. Caliber Imaging & Diagnostics's current Research & Development is $1.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliber Imaging & Diagnostics stock overvalued right now?
Caliber Imaging & Diagnostics (LCDX) has a current Research & Development of $1.47 Mil. The current Research & Development is $1.47 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Caliber Imaging & Diagnostics (LCDX), the current Research & Development is $1.47 Mil as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caliber Imaging & Diagnostics Business Description

Address 50 Methodist Hill Drive, Suite 1000, Rochester, NY, USA, 14623
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.